1.北京中医药大学研究生院,北京 100029
2.首都医科大学附属北京中医医院骨科,北京 100010
王清任,男,25岁,硕士研究生。研究方向:中医药防治骨伤疾病。
彭亚,E-mail:mofan425@sina.com
纸质出版日期:2024-06-25,
收稿日期:2023-02-27,
扫 描 看 全 文
王清任,柳根哲,李浩锌,等.复元活血汤联合经皮椎体后凸成形术治疗骨质疏松性胸腰椎压缩性骨折32例[J].北京中医药,2024,43(6):614-617.
WANG Qingren,LIU Genzhe,LI Haoxin,et al.Fuyuan Huoxue Decoction combined with percutaneous kyphoplasty in the treatment of 32 cases of thoracolumbar vertebral compression fractures[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):614-617.
王清任,柳根哲,李浩锌,等.复元活血汤联合经皮椎体后凸成形术治疗骨质疏松性胸腰椎压缩性骨折32例[J].北京中医药,2024,43(6):614-617. DOI: 10.16025/j.1674-1307.2024.06.008.
WANG Qingren,LIU Genzhe,LI Haoxin,et al.Fuyuan Huoxue Decoction combined with percutaneous kyphoplasty in the treatment of 32 cases of thoracolumbar vertebral compression fractures[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(06):614-617. DOI: 10.16025/j.1674-1307.2024.06.008.
目的
2
探讨复元活血汤联合经皮椎体后凸成形术(percutaneous kyphoplasty,PKP)治疗骨质疏松性胸腰椎压缩性骨折的临床疗效。
方法
2
选择2020年11月—2021年11月首都医科大学附属北京中医医院骨科收治的64例胸腰椎压缩性骨折患者,采用区组随机化分组法分为观察组32例和对照组32例。对照组采用PKP手术治疗;观察组给予PKP手术联合复元活血汤治疗,连服1周。对比2组临床疗效、治疗前后疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI)评分、中医证候积分、伤椎前缘及中线高度。
结果
2
观察组显效率[25.00%(8/32)]高于对照组(0),差异有统计学意义(
P
<
0.05);2组总有效率比较差异无统计学意义(
P
>
0.05)。治疗1周后,2组VAS、ODI评分均较治疗前降低(
P
<
0.05),且观察组VAS、ODI评分低于对照组(
P
<
0.05);2组中医证候积分均较治疗前降低(
P
<
0.05),且观察组低于对照组(
P
<
0.05);2组伤椎前缘及中线高度均较治疗前升高(
P
<
0.05),但2组间差异均无统计学意义(
P
>
0.05)。
结论
2
复元活血汤联合PKP治疗胸腰椎压缩性骨折的疗效确切,可减轻患者疼痛,促进腰椎功能恢复,减轻临床症状。
Objective
2
To investigate the clinical effect of Fuyuan Huoxue Decoction combined with percutaneous kyphoplasty (PKP) in the treatment of thoracolumbar compression fractures.
Methods
2
A total of 64 patients with thoracolumbar vertebral compression fractures, who visited Department of Orthopedics, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University from November 2020 to November 2021, were divided into experimental group and control group by block randomization method. 32 patients in the control group were treated with PKP surgery, and 32 in the experimental group was treated with Fuyuan Huoxue Decoction orally for one week on the basis of the control group. The clinical efficacy, visual analogue scale (VAS), Oswestry dysfunction index (ODI) score, TCM syndrome score, the height of anterior and midline of injured vertebra were compared between the two groups.
Results
2
The effective rate of the experimen
tal group was 25.00% (8/32), which was significantly higher than that of the control group, 0.00% (0/32), and the difference was statistically significant(
P
<
0.05). There was no significant difference in the total effective rate between the two groups(
P
>
0.05).After one week of treatment, VAS and ODI scores of the two groups of patients were significantly lower than those before treatment(
P
<
0.05), and the scores of the experimental group were significantly lower than those of the control group, and the difference was significant(
P
<
0.05). After treatment,the scores of TCM syndromes in both groups were lowered than those before treatment(
P
<
0.05), and the scores of TCM syndromes in the observation group were lowered than those in the control group(
P
<
0.05). The height of the anterior edge of the injured vertebrae and the height of the midline of the injured vertebrae in the two groups were higher than those before treatment(
P
<
0.05), while the recovery degree of the injured vertebral height in the experimental group was not significantly different from that in the control group(
P
>
0.05).
Conclusion
2
Fuyuan Huoxue Decoction combined with PKP is effective in the treatment of thoracolumbar compression fractures, which can significantly reduce pain,help promote the recovery of lumbar vertebtral function and alleviate clinial symptoms.
复元活血汤经皮椎体后凸成形术胸腰椎压缩性骨折椎体高度腰椎功能
Fuyuan Huoxue Decoctionpercutaneous kyphoplastythoracolumbar compression fracturesvertebral body heightlumbar function
裴福兴.骨科学[M].北京:人民卫生出版社,2016:422-423.
MCCARTHY J, DAVIS A. Diagnosis and management of vertebral compression fractures[J]. Am Fam Physician, 2016,94(1):44-50.
张野,夏辉强,易威威,等.经皮椎体后凸成形术与经皮椎弓根螺钉内固定术对骨量减少型胸腰椎压缩性骨折的疗效对比研究[J].创伤外科杂志,2021,23(6):428-434.
LI Y, YUE J, HUANG M, et al. Risk factors for postoperative residual back pain after percutaneous kyphoplasty for osteoporotic vertebral compression fractures[J]. Eur Spine J, 2020,29(10):2568-2575.
刘红财. 复元活血汤联合经皮椎体后凸成形术治疗老年骨质疏松性椎体压缩骨折的临床效果[J]. 内蒙古中医药,2021,40(5):21-22.
丁悦,张嘉,岳华,等.骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(5):425-437.
印平,马远征,马迅,等.骨质疏松性椎体压缩性骨折的治疗指南[J].中国骨质疏松杂志,2015,21(6):643-648.
李冀.方剂学[M].北京:中国中医药出版社,2016:365-366.
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:339-342.
SHAFSHAK TS, ELNEMR R. The visual analogue scale versus numerical rating scale in measuring pain severity and predicting disability in low back pain[J]. J Clin Rheumatol, 2021,27(7):282-285.
何天福, 韩长青, 李立强,等. 手法复位联合中药治疗老年骨质疏松性胸腰椎压缩性骨折的临床疗效[J]. 国际老年医学杂志,2022,43(2):202-205.
王飞,耿成武,田忠固,等.天池伤科整复手法结合经皮穿刺球囊扩张椎体后凸成形术治疗骨质疏松性胸腰椎压缩骨折疗效观察[J].北京中医药,2023,42(9):970-974.
陈激光.胸腰椎压缩性骨折患者PKP术后残余痛的危险因素分析[D].上海:中国人民解放军海军军医大学,2021.
黄桂成.中医骨伤科学[M].北京:中国中医药出版社,2016:123-124.
蒿俊行,王拴虎,张恒云,等.加味当归补血汤对高龄股骨粗隆间骨折患者失血量及骨折愈合的影响[J].北京中医药,2022,41(5):558-561.
张永波, 邓海峰, 王江静,等. 复元活血汤联合经皮穿刺椎体成形术治疗新鲜椎体压缩性骨折的疗效与机制研究[J]. 中国医院用药评价与分析,2022,22(9):1081-1084.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构